New Products: Gentris' Pharmacogenomics Services

Gentris will now offer Affymetrix's DMET Plus as one of its pharmacogenomics services. The Morrisville, NC-based firm said that it recently integrated Affy's GCS3000 platform into its CLIA-certified laboratory and has already commenced a number of clinical studies, including oncology clinical trials, using the DMET Plus assay. DMET Plus allows drug developers to understand how variations in drug metabolism enzymes and drug transporters between patients affects adverse drug responses and treatment efficacy.